煙草在線據(jù)《生物技術(shù)》報道編譯　　星科公司將出售其不再生產(chǎn)的可溶解煙草產(chǎn)品的商標和技術(shù)。

　　在10月3日的一份監(jiān)管文件中，位于弗吉尼亞州的這家公司表示，它已經(jīng)將設(shè)備及存貨出售給以前的一些雇員。

　　與Starion公司的交易的承兌票據(jù)合計將近590,000美元。Starion還將租賃星科公司位于弗吉尼亞州Chase城市的部分設(shè)施，并且支付特許使用費。

　　星科自2001年以來一直在銷售可以在口中溶解的煙草片，但銷量一直偏低。

　　2012年底，該公司停止銷售Ariva和Stonewall產(chǎn)品。其重點轉(zhuǎn)向膳食補充劑，包括其Antabloc消炎產(chǎn)品。

　　該公司的CEO深陷與弗吉尼亞州州長鮑勃·麥克唐納有關(guān)的一個政治丑聞中。

US: Star Scientific Licensing Tobacco Products

　　Star Scientific Inc. is licensing the trademarks and technology for its discontinued dissolvable tobacco products.

　　In a regulatory filing Thursday, the Glen Allen, Va.-based company said it has sold its equipment and inventory to a group of former employees.

　　The transaction with Starion LLC is taking place in promissory notes totaling nearly $590,000. Starion also will lease part of Star Scientific's Chase City, Va., facility and pay royalties.

　　Star Scientific had sold varieties of tobacco lozenges that dissolve in the user's mouth since 2001, but sales had been low.

　　It stopped marketing its Ariva and Stonewall products at the end of 2012. Its focus then shifted dietary supplements, including its Antabloc anti-inflammatory support product.

　　The company's CEO is at the heart of a political scandal involving Virginia Gov. Bob McDonnell. Enditem